Use of Minimal Residual Disease Assessment to Redefine Induction Failure in Pediatric Acute Lymphoblastic Leukemia.
O'Connor D, Moorman AV, Wade R, Hancock J, Tan RM, Bartram J, Moppett J, Schwab C, Patrick K, Harrison CJ, Hough R, Goulden N, Vora A, Samarasinghe S.
O'Connor D, et al. Among authors: goulden n.
J Clin Oncol. 2017 Feb 20;35(6):660-667. doi: 10.1200/JCO.2016.69.6278. Epub 2017 Jan 3.
J Clin Oncol. 2017.
PMID: 28045622